Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), bought 10,000 shares at $1.07 ($11K) on 2025-06-02, disclosed to the SEC on 2025-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |
| ANTX | SELL | 2022-11-09 | $426K | — | Filing → |